PRINCETON, N.J.– July 11, 2018 (BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy
Continue reading »
Removing barriers to advance care planning for cancer patients and their family caregivers
Thinking about death and discussing emotionally challenging topics such as end-of-life preparations are difficult for most people. Patients with advanced
Continue reading »
Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing
Continue reading »
Health Tip: Asbestos Tips For Homeowners
— Asbestos is a mineral fiber that is found in rock and salt. The fibers are strong and heat-resistant, so
Continue reading »
New hope for patients with incurable and disabling hand condition, Dupuytren’s disease
Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians
Continue reading »
New model for predicting neuroblastoma outcomes incorporates early developmental signals
Neuroblastoma, a rare childhood cancer of the sympathetic nervous system, is particularly deadly because it is difficult to detect and
Continue reading »
Vacation Bliss Doesn’t Linger for Tired, Stressed-Out Workers
MONDAY, July 2, 2018 — Taking time off reduces many workers’ stress and re-energizes them, but those benefits disappear once
Continue reading »
Paints, Solvents Tied to Big Rise in MS Risk for Some Smokers
TUESDAY, July 3, 2018 — A triple whammy of genetics, smoking, and exposure to paints and solvents at work puts
Continue reading »
A commonly offered add-on treatment for IVF fails to provide any benefit in a large randomized trial
An add-on treatment commonly offered to female IVF patients to improve their chance of success has been shown in a
Continue reading »
Testosterone increases men’s preference for status goods
A research team led by Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute (ICM—Inserm/CNRS/Sorbonne
Continue reading »